Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Scheid

Showing results (91-100 of 200) with videos related to

Pageof 20
Sort By:
Hemasphere|December 9, 2021
Obinutuzumab in Allogeneic Transplantation for CLL and Richter's Transformation in the Age of Targeted TherapiesNatali Pflug, Geothy Chakupurakal, Anna-Maria Fink, et al.
International Journal of Antimicrobial Agents|December 16, 2011
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trialJ Janne Vehreschild, Gregor Moritz, Maria J G T Vehreschild, et al.
Blood Cancer Journal|April 10, 2019
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trialKatja C Weisel, Christof Scheid, Manola Zago, et al.
Haematologica|January 2, 2015
Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow TransplantationChristian Koenecke, Gudrun Göhring, Liesbeth C de Wreede, et al.
Annals of Hematology|April 2, 2026
How to talk about death? A cross-sectional survey on patients', informal caregivers' and health care professionals' views in the setting of allogenic hematopoietic stem cell transplantationLisanne Preuss, Steffen T Simon, Marco Herling, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 5, 2013
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple MyelomaBritta Auel, Hartmut Goldschmidt, Thomas Geer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2018
Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationThomas Heinicke, Myriam Labopin, Christoph Schmid, et al.
Leukemia & Lymphoma|October 12, 2020
Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMTThomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Bone Marrow Transplantation|September 29, 2019
Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working PartyAbdul Hamid Bazarbachi, Rama Al Hamed, Myriam Labopin, et al.
British Journal of Haematology|March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trialElias K Mai, Axel Benner, Uta Bertsch, et al.
Pageof 20

Showing results (91-100 of 200) with videos related to

Sort By:
Pageof 20
Hemasphere|December 9, 2021
Obinutuzumab in Allogeneic Transplantation for CLL and Richter's Transformation in the Age of Targeted TherapiesNatali Pflug, Geothy Chakupurakal, Anna-Maria Fink, et al.
International Journal of Antimicrobial Agents|December 16, 2011
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trialJ Janne Vehreschild, Gregor Moritz, Maria J G T Vehreschild, et al.
Blood Cancer Journal|April 10, 2019
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trialKatja C Weisel, Christof Scheid, Manola Zago, et al.
Haematologica|January 2, 2015
Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow TransplantationChristian Koenecke, Gudrun Göhring, Liesbeth C de Wreede, et al.
Annals of Hematology|April 2, 2026
How to talk about death? A cross-sectional survey on patients', informal caregivers' and health care professionals' views in the setting of allogenic hematopoietic stem cell transplantationLisanne Preuss, Steffen T Simon, Marco Herling, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 5, 2013
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple MyelomaBritta Auel, Hartmut Goldschmidt, Thomas Geer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2018
Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationThomas Heinicke, Myriam Labopin, Christoph Schmid, et al.
Leukemia & Lymphoma|October 12, 2020
Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMTThomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Bone Marrow Transplantation|September 29, 2019
Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working PartyAbdul Hamid Bazarbachi, Rama Al Hamed, Myriam Labopin, et al.
British Journal of Haematology|March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trialElias K Mai, Axel Benner, Uta Bertsch, et al.
Pageof 20